Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | avrainvillamide | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | quizartinib | CTRPv2 | pan-cancer | AAC | -0.0092 | 0.8 |
mRNA | FK866 | GDSC1000 | pan-cancer | AAC | -0.0079 | 0.8 |
mRNA | ibrutinib | CTRPv2 | pan-cancer | AAC | 0.01 | 0.8 |
mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.031 | 0.8 |
mRNA | YL54 | CTRPv2 | pan-cancer | AAC | 0.0094 | 0.8 |
mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.008 | 0.8 |
mRNA | GDC-0941 | CTRPv2 | pan-cancer | AAC | 0.009 | 0.8 |
mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.8 |
mRNA | FGIN-1-27 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.8 |